Molecular Storage System (MoSS): Intelligent DNA Data Storage
The MoSS project aims to develop a cost-effective DNA data storage system using novel enzymatic synthesis techniques to enable scalable, high-throughput writing of DNA.
Projectdetails
Introduction
Molecular Storage System (MoSS): Intelligent DNA Data Storage
Several groups, including Helixworks, have demonstrated DNA storage systems over the last few years. The information stored has steadily increased from a few kilobytes to several hundred megabytes.
Current Challenges
However, current DNA synthesis techniques based on phosphonamidite chemistry are designed for manufacturing error-free DNA for biological applications. Today, synthetic DNA costs $0.001 per nucleotide, making DNA storage seven orders of magnitude more expensive than tape.
Project Background
Based on results generated from the FET Open project "OligoArchive" (grant agreement 863320), three of the participants (Helixworks Technologies Limited, Imperial College of Science Technology and Medicine, and EURECOM) are seeking to take the OligoArchive results further, through the development of MoSS—a new DNA storage system based on a novel enzymatic technique for writing DNA at scale. This innovation was assessed by the JRC’s Market Creation Potential indicator framework as having a "High" level of market creation potential.
Research Objectives
In MoSS, we will investigate novel enzymatic synthesis techniques that can dramatically reduce the cost of DNA synthesis by exploiting the fact that using DNA as a data storage medium does not require precise, error-free synthesis.
Consortium Expertise
Our consortium members are at the forefront in both:
- Academic research (Imperial, EURECOM) in structural biology (especially DNA-binding proteins), synthetic biology, and automation (including cell-free protein synthesis)
- Industrial research (Helixworks) in pursuing novel, scalable, enzymatic synthesis techniques that can offer a low-cost, high-throughput write path to DNA storage.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.594.615 |
Totale projectbegroting | € 2.594.615 |
Tijdlijn
Startdatum | 1-5-2022 |
Einddatum | 30-4-2024 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- HELIXWORKS TECHNOLOGIES LIMITEDpenvoerder
- EURECOM GIE
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A dynamic, ultra-stable, random-access RNA retrieval databaseThis project aims to develop a regeneratable DNA-based solid-state storage system that allows selective data manipulation and long-term stability using enzymatic reactions and RNA inputs. | EIC Pathfinder | € 1.659.570 | 2023 | Details |
Interoperable end-to-end platform of scalable and sustainable high-throughput technologies for DNA-based digital data storagePEARL-DNA aims to develop a high-throughput, modular DNA-based data storage platform to enhance longevity, efficiency, and integration in sustainable data management solutions. | EIC Pathfinder | € 3.999.857 | 2023 | Details |
DNA Microfactory for Autonomous ArchivingDNAMIC aims to develop an autonomous, low-energy DNA microfactory for end-to-end data archiving, ensuring long-term storage compliance and disaster recovery through innovative encoding schemes. | EIC Pathfinder | € 2.437.522 | 2023 | Details |
MIcrobe-synthesised DNA NAnostructures for DIsplay-controlled Storage CartridgesDevelop a low-cost, energy-efficient data drive using bacterial cells to efficiently write, edit, store, and retrieve DNA-based data for long-term storage. | EIC Pathfinder | € 3.999.506 | 2023 | Details |
A dynamic, ultra-stable, random-access RNA retrieval database
This project aims to develop a regeneratable DNA-based solid-state storage system that allows selective data manipulation and long-term stability using enzymatic reactions and RNA inputs.
Interoperable end-to-end platform of scalable and sustainable high-throughput technologies for DNA-based digital data storage
PEARL-DNA aims to develop a high-throughput, modular DNA-based data storage platform to enhance longevity, efficiency, and integration in sustainable data management solutions.
DNA Microfactory for Autonomous Archiving
DNAMIC aims to develop an autonomous, low-energy DNA microfactory for end-to-end data archiving, ensuring long-term storage compliance and disaster recovery through innovative encoding schemes.
MIcrobe-synthesised DNA NAnostructures for DIsplay-controlled Storage Cartridges
Develop a low-cost, energy-efficient data drive using bacterial cells to efficiently write, edit, store, and retrieve DNA-based data for long-term storage.